FDA Orange Book
Generic for Afinitor
Afinitor contains everolimus. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Afinitor is everolimus. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Afinitor and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Afinitor products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 10MG | Marketed (Rx) | AB | 6 | AB |
| tablet, oral | 2.5MG | Marketed (Rx) | AB | 6 | AB |
| tablet, oral | 5MG | Marketed (Rx) | AB | 6 | AB |
| tablet, oral | 7.5MG | Marketed (Rx) | AB | 6 | AB |
NDA 022334, held by NOVARTIS PHARMACEUTICALS CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic everolimus
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA INC | 210050 | AB (A-rated, therapeutically equivalent) | December 9, 2019 | 10MG, 2.5MG, 5MG, 7.5MG |
| BIOCON PHARMA LTD | 214182 | AB (A-rated, therapeutically equivalent) | February 11, 2021 | 10MG, 2.5MG, 5MG, 7.5MG |
| BRECKENRIDGE PHARMACEUTICAL INC | 205426 | AB (A-rated, therapeutically equivalent) | March 5, 2021 | 10MG, 2.5MG, 5MG, 7.5MG |
| HIKMA PHARMACEUTICALS USA INC | 207486 | AB (A-rated, therapeutically equivalent) | November 23, 2021 | 10MG, 2.5MG, 5MG, 7.5MG |
| NEOCUBES PHARMA LLP | 219955 | AB (A-rated, therapeutically equivalent) | October 30, 2025 | 10MG, 2.5MG, 5MG, 7.5MG |
| APOTEX INC | 218488 | AB (A-rated, therapeutically equivalent) | May 12, 2026 | 10MG, 2.5MG, 5MG, 7.5MG |
Afinitor patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8410131 | November 1, 2025 | Method of use | U-1368 | 022334 |
| 8410131*PED | May 1, 2026 | Method of use | None | 022334 |
| 9006224 | July 1, 2028 | Method of use | U-1681 | 022334 |
Afinitor NDC codes
Questions
Is there a generic for Afinitor?
Yes. The generic name for Afinitor is everolimus. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Afinitor?
The active ingredient in Afinitor is everolimus, per the FDA Orange Book.
When does the Afinitor patent expire?
The last patent listed for Afinitor in the Orange Book expires July 1, 2028. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Afinitor and Everolimus
- What is Everolimus used for?FDA label uses
- Is Everolimus a controlled substance?Federal schedule
- Generic for Afinitor DisperzFDA Orange Book
- Generic for ZortressFDA Orange Book
- Kinase Inhibitors listFDA drug class
- MTOR Inhibitor Immunosuppressants listFDA drug class
- NDC 0078-0566Afinitor NDC record
- NDC 0078-0567Afinitor NDC record
- NDC 0078-0594Afinitor NDC record